RT Journal Article
SR Electronic
T1 Multivariate Analysis for the Influence of Ejection Fraction Value on Propofol Anesthesia Induction Requirement and its Pharmacodynamic Properties in Cardiopulmonary Bypass Surgery (Observational Study based on the Clinical Outcomes)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.28.22282821
DO 10.1101/2022.11.28.22282821
A1 Permeisari, Dias
YR 2022
UL http://medrxiv.org/content/early/2022/11/30/2022.11.28.22282821.abstract
AB Background The majority of propofol utilization as an induction anesthetic in cardiac surgery, particularly in cardiopulmonary bypass surgery led to several risks to the patient. The most common risk is dropped mean arterial pressure, even with the high risk of cardiac arrest.Objective Determining the influences of ejection fraction value on the amount of propofol requirement as an induction agent based on the patient’s primary outcome (BIS spectral index) and the secondary outcomes (mean arterial pressure and heart rate)Design Prospective study, analytical observational with multivariate linear regression analysis, and multicenter studySetting 2 hospitals, including 1 teaching hospital and 1 private hospitalPatients all patients who underwent cardiopulmonary bypass surgery and are eligible for the inclusion criteriaMeasurements Doses of Propofol as an anesthesia induction, mean arterial pressure (MAP) prior to surgery, heart rate (HR) prior to surgery, BIS Spectral Index prior to surgery, MAP after induction, HR after induction, and BIS Spectral Index after inductionResults These data were analyzed using MATLAB R2022a software to obtain R2 (determining the effect size or influences) and p-value for each condition of ejection fraction value and the clinical responses. The data of this observational study is divided into six groups : 1. the effect size of ejection fraction value < 50% on BIS index obtained R2 0.9231 and p-value 0.88, 2. the effect size of ejection fraction value ≥ 50% on BIS index obtained R2 0.7794 and p-value 0.01, 3. the effect size of ejection fraction value < 50% on mean arterial pressure obtained R2 0.00024 and p-value 0.97, 4. The effect size of ejection fraction value ≥ 50% on mean arterial pressure obtained R2 0.0786 and p-value 0.005, 5. The effect size of ejection fraction value < 50% on heart rate obtained R2 0.3992 and p-value 0.06, 6. The effect size of ejection fraction value ≥ 50% on heart rate obtained R2 0.1757 and p-value 7.0776e-04.Conclusions Propofol extremely impacts BIS index value compared to the patient’s mean arterial pressure or heart rate at the induction doses of propofol in general anesthesia for patients with a reduced ejection fractionCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThe author declares no funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I confirm all relevant ethical guidelines have been followed. The Research Ethic Committee of Premier Hospital, Surabaya, Indonesia, has approved this observational study with the protocol number of 01/rps/kers/1/2022, and approval by The Research Ethic Committee of Dr.Soetomo General Hospital, Surabaya, Indonesia, with the protocol number of 0442/KEPK/VII/2022I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript